Today, @SemlerSci launched CardioVanta, a new subsidiary targeting early detection of heart failure and cardiac arrhythmias—multi-billion dollar markets. SMLR is now composed of three valuable components: 1. A 4,440+ BTC treasury built on operating cash flow—and accretive equity and debt issuances. 2. The high-margin QuantaFlo business for early detection of peripheral artery disease (PAD). 3. The newly launched CardioVanta, which will house its future business activities in early detection of heart failure. We believe this structure will help the market more accurately ascribe value to each part of the business. SMLR now operates multiple valuable healthcare businesses. These businesses contain an embedded monetary premium—asset value that we intend to strategically unlock using proceeds from equity and debt financings to accumulate bitcoin. Let’s accelerate to our 2027 EOY goal: 105,000 BTC.